Robert E. McLaughlin

Biochemistry, Genetics and Molecular Biology · Life Sciences

35h-index6.0kcitations94works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antibiotic Resistance in Bacteria(20), Orthopaedic implants and arthroplasty(10), Antibiotics Pharmacokinetics and Efficacy(9), Bacterial Genetics and Biotechnology(8), Antimicrobial Resistance in Staphylococcus(8)

Publications94 total

JointViT: Modeling Oxygen Saturation Levels with Joint Supervision on Long-Tailed OCTA
arXiv (Cornell University)·2024Open Access
Development of a novel loop-mediated isothermal amplification assay for ß-lactamase gene identification using clinical isolates of Gram-negative bacteria
Frontiers in Cellular and Infection Microbiology·2023· 15 citedOpen Access
<i>Neisseria gonorrhoeae</i> Infection in Women Increases With Rising Gonococcal Burdens in Partners: Chlamydia Coinfection in Women Increases Gonococcal Burden
The Journal of Infectious Diseases·2022· 10 citedOpen Access
Susceptibility of Cutibacterium acnes to topical minocycline foam
Anaerobe·2020· 17 citedOpen Access
LB1117 Assessing bacterial susceptibility of FMX101 4% topical minocycline foam
Journal of Investigative Dermatology·2019· 1 citedOpen Access
Development of a Novel Loop-Mediated Isothermal Amplification Method to Detect Guiana Extended-Spectrum (GES) β-Lactamase Genes in Pseudomonas aeruginosa
Frontiers in Microbiology·2019· 30 citedOpen Access
Pseudomonas aeruginosa PcrV and Psl, the Molecular Targets of Bispecific Antibody MEDI3902, Are Conserved Among Diverse Global Clinical Isolates
The Journal of Infectious Diseases·2018· 65 citedOpen Access
Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii
Antimicrobial Agents and Chemotherapy·2017· 61 citedOpen Access
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
Nature Microbiology·2017· 262 cited
Discovery of Imidazo[1,2-<i>a</i>]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) Synthesis
Journal of Medicinal Chemistry·2017· 121 cited
β-Lactamase Characterization of Baseline Pseudomonas aeruginosa (PSA) from Five Ceftazidime-Avibactam (CAZ-AVI) Phase 3 Clinical Trials
Open Forum Infectious Diseases·2017· 2 citedOpen Access
Homologous Recombination within Large Chromosomal Regions Facilitates Acquisition of β-Lactam and Vancomycin Resistance in Enterococcus faecium
Antimicrobial Agents and Chemotherapy·2016· 30 citedOpen Access
Elucidation of Mechanisms of Ceftazidime Resistance among Clinical Isolates of Pseudomonas aeruginosa by Using Genomic Data
Antimicrobial Agents and Chemotherapy·2016· 37 citedOpen Access
Identification of unique in-frame deletions in OprD among clinical isolates of<i>Pseudomonas aeruginosa</i>
Pathogens and Disease·2016· 15 citedOpen Access
Pseudomonas aeruginosa PcrV and Psl Antigens are Conserved in Diverse Hospital Isolates Collected from an International Surveillance Study
Open Forum Infectious Diseases·2016Open Access
Loop-Mediated Isothermal Amplification Assay for β-Lactamase Identification on Clinical Isolates of Pseudomonas aeruginosa
Open Forum Infectious Diseases·2016Open Access
Sulbactam Combined With the Novel β-lactamase Inhibitor ETX2514 for the Treatment of Multidrug-Resistant Acinetobacter baumannii Infections
Open Forum Infectious Diseases·2016· 3 citedOpen Access
Multiyear, Multinational Survey of the Incidence and Global Distribution of Metallo-β-Lactamase-Producing Enterobacteriaceae and Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy·2015· 213 citedOpen Access
Markerless <i>Escherichia coli rrn</i> Deletion Strains for Genetic Determination of Ribosomal Binding Sites
G3 Genes Genomes Genetics·2015· 52 citedOpen Access
Pharmacodynamic Profiling of a Siderophore-Conjugated Monocarbam in Pseudomonas aeruginosa: Assessing the Risk for Resistance and Attenuated Efficacy
Antimicrobial Agents and Chemotherapy·2015· 76 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

James Whiteaker(10), Joseph J. Ferretti(8), Richard A. Alm(6), Humphrey Gardner(5), Alita A. Miller(5), Anisha Ambady(5), W. Michael McShan(4), Sushmita D. Lahiri(4), Jitendar Reddy(4), Vijender Panduga(4), Sreevalli Sharma(4), Vasan K. Sambandamurthy(4), Pravin S. Iyer(4), Shridhar Narayanan(4), Monalisa Chatterji(4), Veronica N. Kos(3), Adam B. Shapiro(3), Sarah M. McLeod(3), Jason Thresher(3), David E. Ehmann(3)